Tom G Martin

11PUBLICATIONS
81CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 03, 2026
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma.

|Feb 24, 2026
Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis.

Carlyn Rose Tan, Saad Z Usmani, Andriy Derkach

|Sep 22, 2025
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study.

Ajai Chari, Niels W C J van de Donk, Bhagirathbhai Dholaria

|Jun 26, 2025
Focusing on Selinexor for Holding and Bridging Prior to CAR-T in Relapsed/Refractory Multiple Myeloma.

Jack Khouri, Douglas Sborov, Adriana Rossi

|Apr 02, 2025
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study.

Carlyn Rose Tan, Sireesha Asoori, Chiung-Yu Huang

|Nov 28, 2024
Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.

Paul G Richardson, Aurore Perrot, Joseph Mikhael

Pageof 2

Frequent Collaborators

3 joint publications

Joaquin Martinez-Lopez

3 joint publications

Albert Oriol

3 joint publications

Joseph Mikhael

3 joint publications

Kwee Yong